Literature DB >> 26134644

Prefrontal and Striatal Glutamate Differently Relate to Striatal Dopamine: Potential Regulatory Mechanisms of Striatal Presynaptic Dopamine Function?

Tobias Gleich1, Lorenz Deserno2, Robert Christian Lorenz3, Rebecca Boehme4, Anne Pankow4, Ralph Buchert5, Simone Kühn6, Andreas Heinz4, Florian Schlagenhauf7, Jürgen Gallinat8.   

Abstract

Theoretical and animal work has proposed that prefrontal cortex (PFC) glutamate inhibits dopaminergic inputs to the ventral striatum (VS) indirectly, whereas direct VS glutamatergic afferents have been suggested to enhance dopaminergic inputs to the VS. In the present study, we aimed to investigate relationships of glutamate and dopamine measures in prefrontostriatal circuitries of healthy humans. We hypothesized that PFC and VS glutamate, as well as their balance, are differently associated with VS dopamine. Glutamate concentrations in the left lateral PFC and left striatum were assessed using 3-Tesla proton magnetic resonance spectroscopy. Striatal presynaptic dopamine synthesis capacity was measured by fluorine-18-l-dihydroxyphenylalanine (F-18-FDOPA) positron emission tomography. First, a negative relationship was observed between glutamate concentrations in lateral PFC and VS dopamine synthesis capacity (n = 28). Second, a positive relationship was revealed between striatal glutamate and VS dopamine synthesis capacity (n = 26). Additionally, the intraindividual difference between PFC and striatal glutamate concentrations correlated negatively with VS dopamine synthesis capacity (n = 24). The present results indicate an involvement of a balance in PFC and striatal glutamate in the regulation of VS dopamine synthesis capacity. This notion points toward a potential mechanism how VS presynaptic dopamine levels are kept in a fine-tuned range. A disruption of this mechanism may account for alterations in striatal dopamine turnover as observed in mental diseases (e.g., in schizophrenia). SIGNIFICANCE STATEMENT: The present work demonstrates complementary relationships between prefrontal and striatal glutamate and ventral striatal presynaptic dopamine using human imaging measures: a negative correlation between prefrontal glutamate and presynaptic dopamine and a positive relationship between striatal glutamate and presynaptic dopamine are revealed. The results may reflect a regulatory role of prefrontal and striatal glutamate for ventral striatal presynaptic dopamine levels. Such glutamate-dopamine relationships improve our understanding of neurochemical interactions in prefrontostriatal circuits and have implications for the neurobiology of mental disease.
Copyright © 2015 the authors 0270-6474/15/359615-07$15.00/0.

Entities:  

Keywords:  FDOPA PET; MRS; dopamine; glutamate; prefrontal cortex; striatum

Mesh:

Substances:

Year:  2015        PMID: 26134644      PMCID: PMC6605144          DOI: 10.1523/JNEUROSCI.0329-15.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  69 in total

Review 1.  Neurotransmitter interactions in schizophrenia--therapeutic implications.

Authors:  A Carlsson; N Waters; M L Carlsson
Journal:  Biol Psychiatry       Date:  1999-11-15       Impact factor: 13.382

2.  Involvement of NMDA and AMPA/kainate receptors in the effects of endogenous glutamate on extracellular concentrations of dopamine and GABA in the nucleus accumbens of the awake rat.

Authors:  G Segovia; F Mora
Journal:  Brain Res Bull       Date:  2001-01-15       Impact factor: 4.077

3.  Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.

Authors:  N Tzourio-Mazoyer; B Landeau; D Papathanassiou; F Crivello; O Etard; N Delcroix; B Mazoyer; M Joliot
Journal:  Neuroimage       Date:  2002-01       Impact factor: 6.556

Review 4.  Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions.

Authors:  Susan R Sesack; David B Carr; Natalia Omelchenko; Aline Pinto
Journal:  Ann N Y Acad Sci       Date:  2003-11       Impact factor: 5.691

5.  Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum.

Authors:  Diana Martinez; Mark Slifstein; Allegra Broft; Osama Mawlawi; Dah-Ren Hwang; Yiyun Huang; Thomas Cooper; Lawrence Kegeles; Eric Zarahn; Anissa Abi-Dargham; Suzanne N Haber; Marc Laruelle
Journal:  J Cereb Blood Flow Metab       Date:  2003-03       Impact factor: 6.200

6.  Injections of N-methyl-D-aspartate into the ventral hippocampus increase extracellular dopamine in the ventral tegmental area and nucleus accumbens.

Authors:  M Legault; R A Wise
Journal:  Synapse       Date:  1999-03-15       Impact factor: 2.562

7.  Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia.

Authors:  Andreas Meyer-Lindenberg; Robert S Miletich; Philip D Kohn; Giuseppe Esposito; Richard E Carson; Mario Quarantelli; Daniel R Weinberger; Karen Faith Berman
Journal:  Nat Neurosci       Date:  2002-03       Impact factor: 24.884

Review 8.  Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment.

Authors:  Marc Laruelle; Lawrence S Kegeles; Anissa Abi-Dargham
Journal:  Ann N Y Acad Sci       Date:  2003-11       Impact factor: 5.691

9.  Exploratory factor analysis of the WAIS-III in a mixed patient sample.

Authors:  J J Ryan; A M Paolo
Journal:  Arch Clin Neuropsychol       Date:  2001-02       Impact factor: 2.813

Review 10.  Molecular brain imaging and the neurobiology and genetics of schizophrenia.

Authors:  A Heinz; B Romero; J Gallinat; G Juckel; D R Weinberger
Journal:  Pharmacopsychiatry       Date:  2003-11       Impact factor: 5.788

View more
  20 in total

1.  Aberrant Frontostriatal Connectivity in Negative Symptoms of Schizophrenia.

Authors:  Dinesh K Shukla; Joshua John Chiappelli; Hemalatha Sampath; Peter Kochunov; Stephanie M Hare; Krista Wisner; Laura M Rowland; L Elliot Hong
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

Review 2.  Direct dopamine terminal regulation by local striatal microcircuitry.

Authors:  Suzanne O Nolan; Jennifer E Zachry; Amy R Johnson; Lillian J Brady; Cody A Siciliano; Erin S Calipari
Journal:  J Neurochem       Date:  2020-06-19       Impact factor: 5.372

3.  The relationship between glutamate, dopamine, and cortical gray matter: A simultaneous PET-MR study.

Authors:  Antoine Rogeau; Giovanna Nordio; Mattia Veronese; Kirsten Brown; Matthew M Nour; Martin Osugo; Sameer Jauhar; Oliver D Howes; Robert A McCutcheon
Journal:  Mol Psychiatry       Date:  2022-05-11       Impact factor: 15.992

4.  Elevated striatal glutamate + glutamine in recreational cannabis users during abstinence.

Authors:  Chun S Zuo; Katherine A Davis; Madeline K Kuppe; M Kathryn Dahlgren; Staci Gruber; Garrett M Fitzmaurice; Scott E Lukas
Journal:  J Psychiatr Res       Date:  2021-12-21       Impact factor: 4.791

Review 5.  Relevance of interactions between dopamine and glutamate neurotransmission in schizophrenia.

Authors:  Silas A Buck; M Quincy Erickson-Oberg; Ryan W Logan; Zachary Freyberg
Journal:  Mol Psychiatry       Date:  2022-06-10       Impact factor: 13.437

Review 6.  The effect of striatal dopamine depletion on striatal and cortical glutamate: A mini-review.

Authors:  Fernando Caravaggio; Shinichiro Nakajima; Eric Plitman; Philip Gerretsen; Jun Ku Chung; Yusuke Iwata; Ariel Graff-Guerrero
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-09-01       Impact factor: 5.067

7.  Dopamine and glutamate in schizophrenia: biology, symptoms and treatment.

Authors:  Robert A McCutcheon; John H Krystal; Oliver D Howes
Journal:  World Psychiatry       Date:  2020-02       Impact factor: 49.548

Review 8.  Towards a Unifying Cognitive, Neurophysiological, and Computational Neuroscience Account of Schizophrenia.

Authors:  Andreas Heinz; Graham K Murray; Florian Schlagenhauf; Philipp Sterzer; Anthony A Grace; James A Waltz
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

Review 9.  Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies.

Authors:  Tomomi Nakahara; Sakiko Tsugawa; Yoshihiro Noda; Fumihiko Ueno; Shiori Honda; Megumi Kinjo; Hikari Segawa; Nobuaki Hondo; Yukino Mori; Honoka Watanabe; Kazuho Nakahara; Kazunari Yoshida; Masataka Wada; Ryosuke Tarumi; Yusuke Iwata; Eric Plitman; Sho Moriguchi; Camilo de la Fuente-Sandoval; Hiroyuki Uchida; Masaru Mimura; Ariel Graff-Guerrero; Shinichiro Nakajima
Journal:  Mol Psychiatry       Date:  2021-09-28       Impact factor: 15.992

10.  Glutamate connectivity associations converge upon the salience network in schizophrenia and healthy controls.

Authors:  Robert A McCutcheon; Toby Pillinger; Maria Rogdaki; Juan Bustillo; Oliver D Howes
Journal:  Transl Psychiatry       Date:  2021-05-27       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.